⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DVAX News
Dynavax Technologies Corporation
Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program
prnewswire.com
DVAX
Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program
prnewswire.com
DVAX
Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile
prnewswire.com
DVAX